Clinical Trial Detail

NCT ID NCT03418038
Title Ascorbic Acid and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Indications

lymphoma

diffuse large B-cell lymphoma

Therapies

Dexamethasone

Carboplatin + Etoposide + Ifosfamide

Carboplatin + Etoposide + Ifosfamide + Rituximab

Cisplatin + Cytarabine + Dexamethasone

Cisplatin + Dexamethasone + Gemcitabine

Rituximab

Cytarabine + Dexamethasone + Oxaliplatin

Gemcitabine + Oxaliplatin

Cisplatin + Cytarabine + Dexamethasone + Rituximab

Age Groups: senior adult

No variant requirements are available.